Sign in Subscribe
Cybernet Data Systems Inc.

NuVasive Appoints Amy Belt Raimundo to Its Board of Directors

Strategic Insights

— 2 min read

NuVasive, a leader in spine technology innovation, has elected Amy Belt Raimundo to its Board of Directors, effective August 9, 2021. Raimundo brings over 20 years of experience in healthcare, with a strong background in medical technology, healthcare strategy, and digital health. She is currently the co-founder and Managing Partner of Convey Capital, a venture capital fund focused on healthcare technology investments.

Raimundo's extensive experience will further NuVasive's ability to change the lives of patients around the globe through its innovative spine surgery solutions. Her expertise in commercializing novel technologies will support the company's long-term strategy for growth. "Amy is a fantastic addition to our Board of Directors, and her deep knowledge of the healthcare landscape will help us drive our vision forward," said J. Christopher Barry, NuVasive's chief executive officer.

Raimundo's accomplishments include serving as Managing Director for Kaiser Permanente Ventures, Chief Business Officer at Evidation Health, and Vice President for Covidien Ventures and Advanced Technology Ventures. She also holds a Bachelor's Degree in economics from Yale University and a Master of Business Administration Degree from the University of California at Berkeley.

Key Takeaways:

  • Amy Belt Raimundo was elected to NuVasive's Board of Directors on August 5, 2021, and will serve as a Class I director, standing for re-election to the Board at the Company's 2023 Annual Meeting of Stockholders.
  • Raimundo brings over 20 years of experience in healthcare, with expertise in medical technology, healthcare strategy, and digital health, and will contribute to NuVasive's long-term strategy for growth.
  • She will receive an annual cash retainer of $70,000 for her Board service, payable quarterly, and a pro-rated annual grant of restricted stock units ("RSUs") on August 9, 2021, subject to vesting on the date of the 2022 Annual Meeting of Stockholders.
  • Raimundo is a Kauffman Fellow and co-founder of MedtechWomen, a nonprofit organization dedicated to highlighting women leaders in the medical technology industry.
  • NuVasive's Board is now comprised of ten directors, nine of whom are independent non-employee directors, following the election of Raimundo to the Board.
  • The company has approximately 2,700 employees and operates in more than 50 countries, serving surgeons, hospitals, and patients worldwide.

Statistics:

  • NuVasive has over $1 billion in net sales.
  • The company operates in more than 50 countries.
  • Raimundo has over 20 years of experience in healthcare.
  • She has served in various leadership roles, including Managing Director for Kaiser Permanente Ventures and Chief Business Officer at Evidation Health.
  • NuVasive's Board of Directors now has ten members, with nine independent non-employee directors.

Sources:

  • NuVasive, Inc. (2021-08-09). News Release: NuVasive Appoints Amy Belt Raimundo to Its Board of Directors. Retrieved from
  • Edgar Online (2021-08-05). FORM 8-K. Retrieved from

Read more